NPD (Phoenix Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the NPD drug offered from Phoenix Pharmaceutical, Inc.. This Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient],Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Phoenix Pharmaceutical, Inc. |
| NON-PROPRIETARY NAME: | Neomycin sulfate, Polymyxin B Sulfate, and Dexamethasone |
| SUBSTANCE NAME: | NEOMYCIN SULFATE; POLYMYXIN B SULFATE; DEXAMETHASONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient],Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | OINTMENT |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 1994-07-25 |
| END MARKETING DATE: | 0000-00-00 |
NPD HUMAN PRESCRIPTION DRUG Details:
| Item Description | NPD from Phoenix Pharmaceutical, Inc. |
| LABELER NAME: | Phoenix Pharmaceutical, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3.5; 10000; 1(mg/g; [USP’U]/g; mg/g) |
| START MARKETING DATE: | 1994-07-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 57319-307_2a1d77e9-c706-4d9b-9745-e93ef4919c8a |
| PRODUCT NDC: | 57319-307 |
| APPLICATION NUMBER: | ANDA064063 |
Other NEOMYCIN SULFATE; POLYMYXIN B SULFATE; DEXAMETHASONE Pharmaceutical Manufacturers / Labelers:
